JPRN-UMIN000031881已完成未知
Clinical Significance of Monitoring by Interferon-Gamma Releasing Assay (IGRA) in Patients with Non-Small Cell Lung Cancer receiving Checkpoint Inhibitor Treatment - Clinical Significance of Monitoring by Interferon-Gamma Releasing Assay (IGRA) in Checkpoint Inhibitor Treatment
Osaka Prefectural Hospital Organization Osaka Habikino Medical Center0 个研究点目标入组 30 人开始时间: 2018年3月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patient with an active heterochronous or synchronous overlap cancer (carcinoma-insitu or cured intramucosal canceris excluded from overlap cancer) 2 Patient with active liver disease (ex. HBV-DNA positive, autoimmune hepatitis, anliver cirrhosis). 3 Female patient with the possibility (intention) of the pregnancy. Patient whom the Doctor in charge judged to be inappropriate as an object of this study.
研究者
相似试验
招募中
3 期
The effect of interferon on the treatment of covid19 patientsIRCT20160118026097N3Ghoum University of Medical Sciences60
招募中
不适用
Sleep electroencephalogram (EEG) recordings in interferon-alpha treated hepatitis C patients – Pilot StudyMood side effects of interferon alpha treatmentMood effects of interferon treatment of hepatitis C patientsMental Health - DepressionACTRN12608000526370nited Hospitals Bristol15
招募中
不适用
Emotional Processing in Interferon-treated Hepatitis C patientsACTRN12608000525381nited Bristol Hospitals50
招募中
不适用
Efficacy and safety of interferon-free treatment in patients with chronic hepatitis Cchronic hepatitis CJPRN-UMIN000037575Osaka university1,000
招募中
不适用
ong-term effect of interferon-free treatment in subjects with hepatitis C virus (HCV)-related decompensated cirhosisdecompensated cirrhosisJPRN-UMIN000034735Osaka University102